drugset / Trial / NCT05632549

The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma

NCT05632549

Phase 3 Unknown 66 enrolled Tanta University
RandomizedParallel-groupSingle-blindTreatment

Summary

The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children with Moderate Persistent Asthma

Timeline

Start
2022-08-08
Primary completion
2024-08-08
Completion
2024-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Biotin Small molecule 5 mg Oral
Subject L-carnitine Other / unclassified 500 mg Oral

Indications